BEIJING, Sept. 8 -- China's self-developed heart stent has won recognition from the international medical community, with its clinical trial results published online in the world-leading medical journal The Lancet earlier this week.
Named Firehawk, the drug-eluting stent was developed by MicroPort Scientific Corporation, a Chinese healthcare company, to treat patients with coronary artery disease.
The metal stent is 86 microns thick, which is roughly the diameter of a human hair. It contains drugs in micro grooves engraved by lasers on the surface, which prevents the drug from leaking during the transportation of the stent.
Clinical trials were conducted in 21 hospitals in 10 European countries from December 2017 to October 2016. Altogether 1,653 patients from the UK, France, Spain, Italy, Belgium, the Netherlands, Poland, Germany, Austria, and Denmark were implanted with the stent.
According to William Wijns, a professor from the National University of Ireland Galway who led the clinical study, this is the first time that China's medical device went through randomized clinical trials in Europe at such a scale.
Results showed that the safety and clinical efficacy of this stent could rival the Xience stent, one of the world's leading drug-eluting stents.
In addition, its unique structure design could save drug dosages, which help prevent side effects such as thrombus after implantation.
According to Chang Zhaohua, CEO of MicroPort Scientific Corporation, they conducted the clinical trial to further test the stent and compare the results with world-leading heart stents.
"The clinical program adopted European medical standards and was operated by European authoritative experts. We hope to win wider recognition from the international medical community," Chang said.
He said this is the first time that clinical data from a China manufactured stent has been published in such a prestigious medical journal.
"The Lancet is very strict about publishing articles, and the review cycle often lasts for months, sometimes even more than a year. It took less than a month for the journal to publish the clinical trial of the stent, and all five peer review experts gave positive feedback," Chang said.
"With its clinical results being validated in such a rigorous peer-reviewed publication, clinicians and patients may have more confidence in the safety and efficacy of the stent," he added.
According to statistics from the National Cardiovascular Center, there were 290 million cardiovascular patients in China in 2017, including 11 million patients with coronary heart disease.
China has a huge demand for medical devices such as heart stents. The market used to be dominated by costly foreign products.
Many Chinese healthcare companies have increased their research and development in high-end medical devices, making them more affordable to the public.
In addition to the heart stent, Chinese companies are making significant progress in developing cost-effective medical devices such as heart pacemakers and automatic protein analyzers.
"We hope the Firehawk stent can help cure more patients on a global scale. We also want to boost Chinese people's confidence in domestic medical products," Chang said.
独自在家也能用的雅思口语练习方法
雅思口语考试中最易被忽视的两个细节
雅思口语考试不会回答怎么办?
攻克雅思口语需要了解的三大策略
剖析中国考生最易犯的六个雅思口语错误
词汇量有限也能考到雅思口语7分
为什么考生在雅思口语考场上会紧张?
雅思口语时尚话题怎么聊?
十大技巧让你完美展现雅思口语
光靠背诵模板不一定能通过雅思口语考试
雅思口语自我练习的掌握方法
影响雅思口语高分的难题:流利性
雅思口语高难度话题解读:艺术
雅思口语材料及范文:Animal话题解读
雅思口语考试的应急思路和技巧
雅思口语素材:复活节介绍
打赢雅思口语战 自信勇气不能少
雅思口语素材:好句推荐-嫉妒是瞎子
雅思口语考试不能缺少的三个要素
雅思口语考试用英音更具有优势
中国考生雅思口语低分的八大原因
雅思口语高分秘籍:八做八不做
如何应对雅思口语高难度话题?
考生对雅思口语考官的常见误区
提高雅思口语可以多看《辛普森一家》
雅思口语考试的两大忌与两选择
雅思口语考试中如何做到流利准确恰当
雅思口语自我练习的方法指导
雅思口语考官到底想考你什么
为什么雅思口语考官不懂你在说什么
不限 |
英语教案 |
英语课件 |
英语试题 |
不限 |
不限 |
上册 |
下册 |
不限 |